MANSC (415-431) (Human) [4993]
MANSC (415-431) (Human)
| SMILES |
CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)O |
| InChIKey |
CCMVMLBWJFAFRO-IAMXVIFYSA-N |
| Sequence |
KRYSRLDYLINGIYVDI |
| HELM |
PEPTIDE1{K.R.Y.S.R.L.D.Y.L.I.N.G.I.Y.V.D.I}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
28 |
| Hydrogen bond donors |
30 |
| Rotatable bonds |
69 |
| Log P |
-5.429 |
| Molecular weight (Da) |
2100.1 |
| Stereochemistry info |
partial |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.